VITROS 5600 Integrated System Software For use in the in-vitro quantitative, semi quantitative, and qualitative measurement of variety of analytes of clinical interest.
Published August 1, 2012 · Recall initiated: May 21, 2012
Summary
FDA records medical device Class II recall Z-2068-2012, published August 1, 2012 and initiated May 21, 2012. Recalling firm: Ortho-Clinical Diagnostics; Status: Terminated; Reported quantity: 1387; Lot: Version 2.0 & Below. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
software automatically switches the lot when a vancomycin (VANC) or valproic acid (VALP) reagent is depleted or the operator manually changes the lot in use causing lack of verification of proper quality assessment.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ortho-Clinical Diagnostics
- Distributor
- Worldwide Distribution - USA (nationwide) and the countries of Australia, New Zealand, Brazil, Canada, Chile, Argentina, Paraquay, Ecuador, Colombia, India, Japan, Mexico, Panama, Singapore, Venezuela, UK, Northern Europe, France, Germany, Italy, Spain and Portugal.
- Lot
- Version 2.0 & Below
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAVITROS Performance Verifier IIApril 3, 2024
- FDAVITROS Performance Verifier IApril 3, 2024
- FDAVITROS XT Chemistry Products TBIL-ALKP Slides (ALKP is not affected) In Vitro Diagnostic use only - The TBILSeptember 2, 2020
- FDAVITROS Chemistry Product Performance Verifier I, Product Code 8231474, UDI # 10758750004577 - Product Usage:June 24, 2020
- FDAVITROS 4600 Chemistry System Software For use in the in-vitro quantitative, semi quantitative, and qualitativeAugust 1, 2012
- FDAIMPAX CV Reporting The Results Management (RM)/IMPAX CV reporting component facilitates the quick, effectiveAugust 1, 2012
Questions about this recall
Was VITROS 5600 Integrated System Software For use in the in-vitro quantitative, semi quantitative, and qualitative measurement of variety of analytes of clinical interest. recalled?
Yes. FDA published recall Z-2068-2012 on August 1, 2012. Reported hazard: software automatically switches the lot when a vancomycin (VANC) or valproic acid (VALP) reagent is depleted or the operator manually changes the lot in use causing lack of verification of proper quality assessment.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit